David Fuchs

1.1k total citations
12 papers, 440 citations indexed

About

David Fuchs is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Fuchs has authored 12 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Genetics and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Fuchs's work include Multiple Myeloma Research and Treatments (2 papers), Cancer survivorship and care (2 papers) and Advanced Breast Cancer Therapies (1 paper). David Fuchs is often cited by papers focused on Multiple Myeloma Research and Treatments (2 papers), Cancer survivorship and care (2 papers) and Advanced Breast Cancer Therapies (1 paper). David Fuchs collaborates with scholars based in Austria, Germany and United States. David Fuchs's co-authors include Oliver Liesenfeld, André Fischer, Stefan Bereswill, Markus M. Heimesaat, Ildikò Rita Dunay, Ulf B. Göbel, Dorothee Maria Gescher, Ralf R. Schumann, Annette Moter and Andrew Davies and has published in prestigious journals such as The Journal of Immunology, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

David Fuchs

12 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Fuchs Austria 8 124 106 97 80 80 12 440
Katrin Mair Germany 4 246 2.0× 89 0.8× 38 0.4× 38 0.5× 39 0.5× 4 459
Kathleen McCoy Switzerland 3 270 2.2× 108 1.0× 126 1.3× 36 0.5× 19 0.2× 3 449
Roland Ruscher Australia 10 147 1.2× 55 0.5× 93 1.0× 44 0.6× 17 0.2× 23 523
Victoria Camerini United States 11 90 0.7× 88 0.8× 23 0.2× 30 0.4× 41 0.5× 15 694
Claudia M. Trujillo‐Vargas Colombia 13 105 0.8× 56 0.5× 45 0.5× 55 0.7× 24 0.3× 31 586
Oswaldo Partida‐Rodríguez Mexico 11 141 1.1× 125 1.2× 153 1.6× 18 0.2× 14 0.2× 15 401
Hirotaka Igarashi Japan 14 291 2.3× 116 1.1× 10 0.1× 38 0.5× 62 0.8× 35 552
Annette Wunderlich Germany 15 147 1.2× 96 0.9× 179 1.8× 81 1.0× 23 0.3× 24 553
M. Christine Thurnheer United States 8 161 1.3× 98 0.9× 17 0.2× 22 0.3× 43 0.5× 10 596
Holly Turula United States 12 93 0.8× 183 1.7× 22 0.2× 41 0.5× 12 0.1× 15 549

Countries citing papers authored by David Fuchs

Since Specialization
Citations

This map shows the geographic impact of David Fuchs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Fuchs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Fuchs more than expected).

Fields of papers citing papers by David Fuchs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Fuchs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Fuchs. The network helps show where David Fuchs may publish in the future.

Co-authorship network of co-authors of David Fuchs

This figure shows the co-authorship network connecting the top 25 collaborators of David Fuchs. A scholar is included among the top collaborators of David Fuchs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Fuchs. David Fuchs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Fuchs, David, Carina Wagner, Johannes Grillari, et al.. (2024). The Multifaceted Actions of PVP–Curcumin for Treating Infections. International Journal of Molecular Sciences. 25(11). 6140–6140. 1 indexed citations
2.
3.
Davies, Andrew, et al.. (2019). MASCC recommendations on the management of constipation in patients with advanced cancer. Supportive Care in Cancer. 28(1). 23–33. 32 indexed citations
4.
Balić, Marija, Wolfgang Hilbe, Michael Fiegl, et al.. (2019). Prevalence of comorbidity in cancer patients scheduled for systemic anticancer treatment in Austria. memo - Magazine of European Medical Oncology. 12(4). 290–296. 8 indexed citations
5.
Rinnerthaler, Gabriel, Simon Peter Gampenrieder, Andreas Petzer, et al.. (2018). Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial). BMC Cancer. 18(1). 1074–1074. 12 indexed citations
6.
Westphal, Theresa, Gabriel Rinnerthaler, Simon Peter Gampenrieder, et al.. (2018). Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trial. Cancer Medicine. 7(12). 5962–5972. 23 indexed citations
7.
Fuchs, David. (2018). Diffuse large B‑cell lymphoma. memo - Magazine of European Medical Oncology. 12(1). 7–11. 3 indexed citations
8.
Singer, Christian F., Yen Y. Tan, Florian Fitzal, et al.. (2017). Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer. Clinical Cancer Research. 23(14). 3676–3683. 32 indexed citations
9.
Fuchs, David, et al.. (2017). Torsade de pointes in a patient with severe hypercalcaemia and multiple myeloma.. PubMed. 75(5). 208–210. 1 indexed citations
10.
11.
Heimesaat, Markus M., Ildikò Rita Dunay, David Fuchs, et al.. (2011). Selective gelatinase blockage ameliorates acute DSS colitis. European Journal of Microbiology and Immunology. 1(3). 228–236. 20 indexed citations
12.
Heimesaat, Markus M., Stefan Bereswill, André Fischer, et al.. (2006). Gram-Negative Bacteria Aggravate Murine Small Intestinal Th1-Type Immunopathology following Oral Infection with Toxoplasma gondii. The Journal of Immunology. 177(12). 8785–8795. 298 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katrin Mair Breakdown of academic impact, for papers by Kathleen McCoy Breakdown of academic impact, for papers by Roland Ruscher Breakdown of academic impact, for papers by Victoria Camerini Breakdown of academic impact, for papers by Claudia M. Trujillo‐Vargas Breakdown of academic impact, for papers by Oswaldo Partida‐Rodríguez Breakdown of academic impact, for papers by Hirotaka Igarashi Breakdown of academic impact, for papers by Annette Wunderlich Breakdown of academic impact, for papers by M. Christine Thurnheer Breakdown of academic impact, for papers by Holly Turula
Rankless by CCL
2026